Sirius

Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference

Retrieved on: 
fredag, april 26, 2024
Biotechnology, Health, Genetics, Science, Research, MALDI, RUO, Yeast, Infection, Gastroenteritis, Piperacillin/tazobactam, HAI, Hospital, Antimalarial medication, Certification, Mycobacterium tuberculosis, Fungal infection, Bacteria, ESCMID, Daptomycin, Patient, Microbiology, Acquisition, Multimedia, Gram-negative bacteria, Diagnosis, Colistin, IVDR, TB, IVD, Sepsis, MBT, Sirius, Vaccine

At the ESCMID Global 2024 conference, Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibility testing (AST), early sepsis diagnostics, and other infectious disease assays.

Key Points: 
  • At the ESCMID Global 2024 conference, Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibility testing (AST), early sepsis diagnostics, and other infectious disease assays.
  • Simplifying microbiology and infectious disease diagnostics and workflows in the clinical laboratory is a key goal for Bruker in support of earlier and improved patient treatment decisions.
  • Bruker offers additional clinical workflows for rapid functional antibiotic resistance testing, like the MBT STAR®-Carba IVD assay for the detection of carbapenemase activity.
  • Dr. Wolfgang Pusch, President of the Bruker Microbiology & Infection Diagnostics division, commented: “Bruker is committed to innovation in routine microbiology and infectious disease testing.

New Documentary to Highlight the Return to Vietnam 50 Years Later

Retrieved on: 
onsdag, mars 13, 2024
Culture, Sirius, Veteran, Transport, Beauty, Travel, History, Sirius XM, Wreaths Across America, Army

Click here to view a short preview of the documentary.

Key Points: 
  • Click here to view a short preview of the documentary.
  • “The documentary offers an intimate and compelling look at the journey of these veterans,” said videographer Nicholas Mott.
  • “Capturing the essence of their experiences and the profound impact of the Mission Veteran Expedition was truly an honor.
  • “For many veterans, the memories associated with Vietnam are often intertwined with the challenges of war.

13 APAC Mobile Wallet and Digital Bank Leaders Sign up for New MSME Initiative to Accelerate Inclusion and Sustainability Efforts

Retrieved on: 
tisdag, mars 26, 2024
Payments, Finance, Environmental, Social and Governance (ESG), Banking, Professional Services, Technology, Fintech, Online Privacy, TrueMoney, Automation, DANA, Employment, Climate change, Sirius, Face, BKash, Biophysical environment, Corporation, Education, ESG, Knowledge, Growth, Private sector, Carbon, World Bank Group, Social, MSME, International Finance Corporation, Money, Workforce, Monetary Authority of Singapore, South Korea, Multimedia, GCash, MAS

International Finance Corporation (IFC), a member of the World Bank Group, will collaborate with Ant International to develop and promote a set of Digital Sustainability Impact Management Toolkits in the next two years.

Key Points: 
  • International Finance Corporation (IFC), a member of the World Bank Group, will collaborate with Ant International to develop and promote a set of Digital Sustainability Impact Management Toolkits in the next two years.
  • Corporates and businesses today face increasing reporting requirements from regulators, financial institutions, and supply chain partners to disclose and track their sustainability performances.
  • “We always talk about financial and digital inclusion, but sustainability inclusion for MSMEs is becoming one of the most pressing challenges,” said Leiming Chen, Chief Sustainability Officer, Ant International.
  • With this, GCash has become their bridge to digital by providing essential tools – transforming the way they do business.

Women In Trucking Association Announces 2024 Drivers of the Year

Retrieved on: 
måndag, mars 25, 2024
Professional, Water, Truckers Against Trafficking, Face, Sirius, Mentorship, Penske Corporation, Transport, NBC, Silver, Bronze, Research, Female, Smith, News, Road Dog Trucking, Month, Human, MATS, Senior, J. B. Hunt, TAT, Publication, WMCA, Safety, Salute, WIT, The Wall Street Journal, Sirius XM

LOUISVILLE, Ky., March 25, 2024 /PRNewswire-PRWeb/ -- The Women In Trucking Association (WIT) announced on Friday three drivers as the winners of the fifth annual Driver of the Year award sponsored by Walmart.

Key Points: 
  • The Women In Trucking Association (WIT) announced on Friday three drivers as the winners of the fifth annual Driver of the Year award sponsored by Walmart.
  • LOUISVILLE, Ky., March 25, 2024 /PRNewswire-PRWeb/ -- The Women In Trucking Association (WIT) announced on Friday three drivers as the winners of the fifth annual Driver of the Year award sponsored by Walmart.
  • The 2024 Drivers of the Year are:
    The announcement was made during the Salute to Women Behind the Wheel event, hosted by WIT at the Mid-America Trucking Show (MATS) in Louisville, KY.
  • The event honors female commercial drivers for their efforts and successes in the trucking industry.

Bernstein Litowitz Berger & Grossmann LLP Announces Notice of Pendency and Proposed Settlement of Stockholder Class and Derivative Action Involving Holders of Sirius XM Holdings Inc. Common Stock as of the Close of Trading on January 5, 2024

Retrieved on: 
måndag, februari 19, 2024
Court, READ, Hearing, Person, ARE, Telephone, Release, Liberty Media, Judgement, Prejudice, Episcopal conference, Settlement date, Justice Center, Action, CLASS, Sirius XM, PO, Notice, Fee, Sirius, Settlement, Defendant, Eligibility, Compromise, Effective date, Agreement, Post office box, Insurance

OF STOCKHOLDER CLASS AND DERIVATIVE ACTION,

Key Points: 
  • OF STOCKHOLDER CLASS AND DERIVATIVE ACTION,
    TO:  All holders of Sirius XM Holdings Inc. ("Sirius XM" or the "Company") common stock as of the close of trading on January 5, 2024 (the "Settlement Date") (the "Settlement Class").
  • Certain persons and entities are excluded from the Settlement Class by definition, as set forth in the full Notice of Pendency and Proposed Settlement of Stockholder Class and Derivative Action, Settlement Hearing, and Right to Appear (the "Notice"), available at www.SiriusXMStockholdersLitigation.com .
  • YOUR RIGHTS WILL BE AFFECTED BY A CLASS AND DERIVATIVE ACTION LAWSUIT PENDING IN THIS COURT.
  • All questions about this Summary Notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed to the Settlement Administrator or Plaintiff's Lead Counsel.

Sirius Therapeutics Begins Phase 1 Clinical Trial of Next-Generation, Long-Acting Factor XI siRNA Anticoagulant for Treatment of Thromboembolic Disorders

Retrieved on: 
fredag, februari 2, 2024
Biotechnology, Health, Clinical Trials, Cardiology, Therapy, Pharmacokinetics, FXI, IND, Small RNA, Dyslipidemia, Sirius, Pharmaceutical industry

Sirius Therapeutics, announced it has dosed the first subject in a Phase 1, first-in-human clinical trial in Australia of SRSD107 on January 30th 2024, its next generation siRNA therapeutic targeting coagulation Factor XI (FXI), for the prevention and treatment of thromboembolic disorders.

Key Points: 
  • Sirius Therapeutics, announced it has dosed the first subject in a Phase 1, first-in-human clinical trial in Australia of SRSD107 on January 30th 2024, its next generation siRNA therapeutic targeting coagulation Factor XI (FXI), for the prevention and treatment of thromboembolic disorders.
  • SRSD107 is the second clinical candidate in the company’s portfolio of next generation siRNA therapeutics to treat cardiovascular diseases.
  • The company recently began clinical trials of SRSD101 in China for the treatment of dyslipidemia following IND clearance from the China National Medical Products Administration.
  • “This trial is based on in vivo studies that demonstrated a nearly 100% reduction of FXI levels for up to 6 months, without bleeding events, after a single subcutaneous dose,” said Dr. Qunsheng Ji, Sirius Therapeutics’ Chief Executive Officer.

Nokia 5G Core SaaS and Network as Code platform to be used by Telia Finland in new Sirius Program  

Retrieved on: 
tisdag, december 12, 2023
Cloud, Senior, Partnership, Sirius, Software, Software as a service, Software development kit, Transport, SDK, API

Nokia 5G Standalone Core in a Software-as-a-Service (SaaS) delivery model and Nokia’s Network as Code platform to give Sirius Program and Telia Finland greater business agility and faster time to value for monetizing innovative 5G network services.

Key Points: 
  • Nokia 5G Standalone Core in a Software-as-a-Service (SaaS) delivery model and Nokia’s Network as Code platform to give Sirius Program and Telia Finland greater business agility and faster time to value for monetizing innovative 5G network services.
  • Telia Finland is using European Union funding to help with the creation of 5G SA corridors among highways and seaways for the innovation program, Sirius.
  • It will also help the operator monetize this 5G network in new and innovative ways beyond connectivity in a SaaS first model.
  • Nokia Core SaaS moves operators and enterprises away from the legacy practice of deploying customized software run on private infrastructure.

Sirius Therapeutics Announces Submission to Begin First Clinical Trial of Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders

Retrieved on: 
fredag, november 10, 2023
Cardiology, Biotechnology, Other Health, Health, General Health, Pharmaceutical, Other Science, Research, Genetics, Science, Clinical Trials, Medicine, Sirius, Clinical trial, Pharmacology, Patient, Therapy, FXI, Pharmaceutical industry

Sirius Therapeutics today announced it has submitted an application in Australia to begin a first-in-human clinical trial of SRSD107, its next generation siRNA therapeutic for the prevention and treatment of thromboembolic disorders.

Key Points: 
  • Sirius Therapeutics today announced it has submitted an application in Australia to begin a first-in-human clinical trial of SRSD107, its next generation siRNA therapeutic for the prevention and treatment of thromboembolic disorders.
  • SRSD107, which specifically targeting coagulation factor XI (FXI), is the first Sirius-developed compound to reach clinical stage of development globally.
  • “We have made rapid progress in developing SRSD107 and other candidates in our pipeline since Sirius was established two years ago.
  • This submission marks our transition from discovery to clinical stage development,” said Dr. Qunsheng Ji, Sirius Therapeutics Chief Executive Officer.

Insider Announces 110+ New Customers, Unveils World's Most Advanced Generative AI Solution for CX, Sirius AI™, and Launches Industry-Leading Capabilities in Q3'23

Retrieved on: 
torsdag, november 9, 2023
E-commerce, LLM, Customer data platform, Meta, Service, Digital, Risk, AWS, GDPR, Marketing, Extract, transform, load, CX, Human, Lightning, PwC, Personal software process, Workforce, News, Acquisition, Personalization, QNB, Mobile marketing, Machine learning, Magic Quadrant, Data activism, Synthetic media, IDC, Nike, WhatsApp, CDP, Travel, CCPA, Communication, SMS, Insider, API, Sirius, City, CTAS, Amplitude, Services and supports for people with disabilities, Consultant, Algorithm, Sales, Tourism, Online shopping, Mobile phone, New Balance, Unilever, Twilio, ShopRite, Pixmania, Adjustment, LinkedIn, Gartner, G2

Insider continues to pave the way in revolutionizing CX and making marketing teams more efficient and productive.

Key Points: 
  • Insider continues to pave the way in revolutionizing CX and making marketing teams more efficient and productive.
  • In Gartner's Magic Quadrant for Personalization Engines 2023 , Insider became the fastest-moving player, making the biggest leaps for three consecutive years.
  • Insider also achieved the highest scores in all three personalization use cases – Marketing (3.99/5.0), Digital Commerce (4.11/5.0), and Services and Support (3.94/5.0).
  • Earlier this quarter, Insider unveiled Sirius AI™ , the world's leading Generative AI solution designed to transform customer experience creation at every level.

Insider Named a Leader in the IDC MarketScape: Worldwide Omnichannel Marketing Platforms for B2C Enterprises 2023

Retrieved on: 
torsdag, september 28, 2023
Omni, IDC, WhatsApp, Analytics, Virginity, AMP, Marketing, Integration, Omnichannel, Synthetic media, Vision, CX, Samsung, Research, AOV, SMS, GAP, Slazenger, Sirius, CNN, NPS, MAC, Singapore Airlines, Allianz, B, Marks & Spencer, CRM, Loyalty, Cosmetics, MAC Cosmetics, Entrepreneurship, Growth, AI, ROI, Coca-Cola, Burger King, Commerce, Mobile phone, Sales, Retail, Insider, Adidas, Lenovo, Vodafone

NEW YORK, Sept. 28, 2023 /PRNewswire/ -- Insider, one platform for building individualized, cross-channel customer experiences, today announced it has been named as a Leader in the IDC MarketScape: Worldwide Omni-Channel Marketing Platforms for B2C Enterprises 2023 Vendor Assessment (doc #US49727423, August 2023).

Key Points: 
  • NEW YORK, Sept. 28, 2023 /PRNewswire/ -- Insider , one platform for building individualized, cross-channel customer experiences, today announced it has been named as a Leader in the IDC MarketScape: Worldwide Omni-Channel Marketing Platforms for B2C Enterprises 2023 Vendor Assessment (doc #US49727423, August 2023).
  • The first-ever IDC MarketScape report on Omnichannel Marketing Platforms covers 14 worldwide Omnichannel Marketing vendors based on their product capabilities and market strategy.
  • The IDC MarketScape recognizes Insider as a Leader, noting that it "supports an impressive array of multichannel marketing tactics including email, marketing, website personalization, push notifications, and in-app messaging."
  • Read the report excerpt to find out why Insider has been named a Leader by the IDC MarketScape.